This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Precision medicine is a medical practice that tailors treatments to individual patients based on their genetic makeup. It is an emerging field in healthcare that incorporates data from a variety of sources, such as genomic sequencing, medical history, lifestyle, and environmental factors, to provide personalized medical care. The goal of precision medicine is to use the most appropriate treatments for each patient, based on their individual characteristics, to improve patient outcomes. It is based on the idea that a person’s genetic makeup can significantly influence their response to treatments, and that treatments should be tailored to the individual patient. For example, if a patient has a certain genetic mutation that causes a certain disease, they may respond differently to a treatment than another patient with a different mutation. Precision medicine uses the patient’s genetic information to determine the most effective treatment for them. It also takes into account factors like lifestyle, environment, and medical history. For example, a patient with a genetic mutation that causes a certain disease may respond differently to a treatment if they are exposed to certain environmental factors. Precision medicine takes this into account when developing a treatment plan for the patient. In addition to personalized treatment plans, precision medicine also allows doctors to better diagnose and monitor diseases.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States